Anuh Pharma Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Anuh Pharma Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
167.80% Gain from 52W Low
4
TTM PE Ratio
Below industry Median
19.5
Price to Book Ratio
Above industry Median
4
Dividend yield 1yr %
Below industry Median
0.9
TTM PEG Ratio
PEG TTM is less than 1
0.3
RSI
RSI is mid-range
46.6
MFI
MFI is mid-range
44.5

Anuh Pharma Ltd shareholding Pattern

Promoter
69.9%
Domestic Institutions
0.1%
Public
30%
Promoter
69.9%
Public
30%
Promoter
70.6%
Public
29.4%
Promoter
70.6%
Public
29.4%
Promoter
70.6%
Public
29.4%
Promoter
70.6%
Public
29.4%

Anuh Pharma Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
10
5Day EMA
236.00
10Day EMA
237.70
12Day EMA
238.00
20Day EMA
238.60
26Day EMA
238.30
50Day EMA
232.70
100Day EMA
214.20
200Day EMA
184.60
5Day SMA
238.30
10Day SMA
239.80
20Day SMA
239.70
30Day SMA
239.20
50Day SMA
238.10
100Day SMA
212.20
150Day SMA
189.50
200Day SMA
175.20
Delivery & Volume
Resistance & Support
233.42
Pivot
Resistance
First Resistance
236.83
Second Resistance
240.42
Third Resistance
243.83
Support
First Support
229.83
Second support
226.42
Third Support
222.83
Relative Strength Index
46.55
Money Flow Index
44.50
MACD
-0.28
MACD Signal
0.72
Average True Range
12.43
Average Directional Index
9.26
Rate of Change (21)
-1.19
Rate of Change (125)
41.58
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Kopran Ltd.
1135.36
140
292.4
Lincoln Pharmaceuticals Ltd.
1134.68
365.4
754.25
Anuh Pharma Ltd.
-
-
-
Syncom Formulation (India) Ltd.
-
-
-
Beta Drugs Ltd.
-
-
-
Zota Healthcare Ltd.
-
-
-
Windlas Biotech Ltd.
1285.25
260
645

Anuh Pharma Ltd Company background

Founded in: 1960
Managing director: Ritesh B Shah
Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of Bulk drugs and chemicals Their products are antibiotics, erythromycin salts, chloramphenicol and other chemicals. The company is part of the SK Group.Anuh Pharma Ltd was incorporated on February 19, 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs.The business headquarters of the firm is located in the commercial capital of India, Mumbai. The company is a recognized export house and exports their products to Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore and several other countries.During the year 200607, the company commissioned the new plant with all latest modern techniques and facilities. Thus, the production capacity of Antibiotics increased from 400,000 Kg to 600,000 Kg.During the year 200809, the company completed the ongoing expansion of their plant, thus they increased the installed capacity by 150 MT per annum. In September 2008, they expanded unit started commercial production.In January 2010, the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption.In April 2010, the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption.In June 2010, the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption.The erection of a new plant for manufacture of drug intermediates, was completed during the year 201011 and it got commissioned towards end of February, 2011. In 2012, it received WHO PQ for Pyrazinamide acquired RD assets in Mahape, Navi Mumbai got DSIR approval. In 2014, it got approval from COFEPRIS Mexico for Erythromycin Estolate, Erythromycin Stearate, Erythromycin Ethyl Succinate. In 2015, it received approval of WHO PQ for Sulfadoxine.In March 2019, the Company opened new expansion with an additional capacity of 900 MTPA for 20 different products. It received CEP for Ambroxol Hydrochloride from EDQM in 2022.
Read More

Anuh Pharma Ltd FAQs

You can easily buy Anuh Pharma Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage